Status:
COMPLETED
Evaluation of Posterior Capsule Opacification in Eyes With Diabetes Mellitus
Lead Sponsor:
Iladevi Cataract and IOL Research Center
Conditions:
Development of Posterior Capsule Opacification
Eligibility:
All Genders
50-75 years
Brief Summary
To compare the development of posterior capsule opacification (PCO) between eyes with and without a history of diabetes mellitus (DM) after single-piece hydrophobic acrylic intraocular lens (IOL) impl...
Detailed Description
There is a paucity of available literature that prospectively evaluates the development of PCO with the single-piece hydrophobic acrylic IOL implantation in diabetic versus non-diabetic eyes on a long...
Eligibility Criteria
Inclusion
- Diabetes mellitus was defined as glycosylated haemoglobin (Hb A1c ) levels of 6% or more ,
- use of diabetic medication (oral hypoglycemic agents, insulin injection or diet restriction), or a physician's diagnosis of diabetes.
- Patients with uncomplicated age-related cataract who were otherwise healthy constituted the controls (n=75 eyes).
Exclusion
- patients with glaucoma,
- high myopia (axial length \> 27.0 mm),
- pseudoexfoliation,
- traumatic cataract,
- subluxated cataract,
- previous ocular surgeries,
- allergy to dilating drops.
Key Trial Info
Start Date :
June 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01480934
Start Date
June 1 2005
End Date
June 1 2010
Last Update
November 29 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.